SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-015594
Filing Date
2020-06-23
Accepted
2020-06-23 17:15:03
Documents
53
Period of Report
2020-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea123278-8k_compasstherap.htm 8-K 1453320
2 AGREEMENT AND PLAN OF MERGER, DATED JUNE 17, 2020. ea123278ex2-1_compass.htm EX-2.1 335775
3 CERTIFICATE OF MERGER ea123278ex3-1_compass.htm EX-3.1 7038
4 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ea123278ex3-2_compass.htm EX-3.2 34978
5 AMENDED AND RESTATED BYLAWS ea123278ex3-3_compass.htm EX-3.3 124588
6 2020 STOCK OPTION AND INCENTIVE PLAN ea123278ex10-1_compass.htm EX-10.1 93276
7 2020 SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN ea123278ex10-2_compass.htm EX-10.2 15975
8 OFFER LETTER, DATED NOVEMBER 8, 2017, BETWEEN VERED BISKER-LEIB AND COMPASS THER ea123278ex10-3_compass.htm EX-10.3 12041
9 FORM OF INDEMNIFICATION AGREEMENT (DIRECTORS) ea123278ex10-4_compass.htm EX-10.4 74145
10 FORM OF INDEMNIFICATION AGREEMENT (EXECUTIVE OFFICERS) ea123278ex10-5_compass.htm EX-10.5 71028
11 FORM OF PRE-MERGER INDEMNIFICATION AGREEMENT (DIRECTORS AND EXECUTIVE OFFICERS) ea123278ex10-6_compass.htm EX-10.6 51807
12 REGISTRATION RIGHTS AGREEMENT, DATED JUNE 19, 2020. ea123278ex10-7_compass.htm EX-10.7 173767
13 SUBSCRIPTION AGREEMENT, DATED JUNE 19, 2020. ea123278ex10-8_compass.htm EX-10.8 338129
14 AMENDED AND RESTATED COLLABORATION AGREEMENT, DATED FEBRUARY 11, 2015. ea123278ex10-9_compass.htm EX-10.9 390120
15 LOAN AND SECURITY AGREEMENT, DATED MARCH 30, 2018. ea123278ex10-10_compass.htm EX-10.10 216772
16 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED SEPTEMBER 26, 2018. ea123278ex10-11_compass.htm EX-10.11 17817
17 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED MARCH 8, 2019. ea123278ex10-12_compass.htm EX-10.12 13572
18 THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED OCTOBER 29, 2019. ea123278ex10-13_compass.htm EX-10.13 21273
19 SUBLEASE AGREEMENT, DATED JULY 29, 2016. ea123278ex10-14_compass.htm EX-10.14 1026001
20 SUBLEASE MODIFICATION AGREEMENT, DATED JANUARY 17, 2018. ea123278ex10-15_compass.htm EX-10.15 43914
21 LETTER FROM RAICH ENDE MALTER & CO. LLP ea123278ex16-1_compass.htm EX-16.1 2123
22 SUBSIDIARIES OF THE REGISTRANT ea123278ex21-1_compass.htm EX-21.1 4825
23 AUDITED FINANCIAL STATEMENTS OF COMPASS THERAPEUTICS, LLC AS OF AND FOR THE FISC ea123278ex99-1_compass.htm EX-99.1 614628
24 UNAUDITED FINANCIAL STATEMENTS OF COMPASS THERAPEUTICS, LLC AS OF AND FOR THE QU ea123278ex99-2_compass.htm EX-99.2 330226
25 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS AS OF AND FOR THE FISCAL YEAR ea123278ex99-3_compass.htm EX-99.3 90038
26 PRESS RELEASE DATED JUNE 23, 2020 ea123278ex99-4_compass.htm EX-99.4 10787
27 GRAPHIC image_001.jpg GRAPHIC 56772
28 GRAPHIC image_002.jpg GRAPHIC 93966
29 GRAPHIC image_003.jpg GRAPHIC 44348
30 GRAPHIC image_004.jpg GRAPHIC 92391
31 GRAPHIC image_005.jpg GRAPHIC 74948
32 GRAPHIC image_006.jpg GRAPHIC 49407
33 GRAPHIC image_007.jpg GRAPHIC 138571
34 GRAPHIC image_008.jpg GRAPHIC 90969
35 GRAPHIC image_009.jpg GRAPHIC 56243
36 GRAPHIC image_010.jpg GRAPHIC 79048
37 GRAPHIC image_011.jpg GRAPHIC 114680
38 GRAPHIC image_012.jpg GRAPHIC 13570
39 GRAPHIC image_013.jpg GRAPHIC 40765
40 GRAPHIC image_014.jpg GRAPHIC 73197
41 GRAPHIC image_015.jpg GRAPHIC 67817
42 GRAPHIC image_016.jpg GRAPHIC 33391
43 GRAPHIC image_018.jpg GRAPHIC 57137
44 GRAPHIC image_019.jpg GRAPHIC 29834
45 GRAPHIC image_020.jpg GRAPHIC 12300
46 GRAPHIC image_021.jpg GRAPHIC 64864
47 GRAPHIC image_022.jpg GRAPHIC 67117
48 GRAPHIC image_023.jpg GRAPHIC 20456
49 GRAPHIC ex10-3_001.jpg GRAPHIC 15186
50 GRAPHIC ex10-14_001.jpg GRAPHIC 346873
51 GRAPHIC ex10-14_002.jpg GRAPHIC 425477
52 GRAPHIC ex10-14_003.jpg GRAPHIC 18572
53 GRAPHIC ex10-14_005.jpg GRAPHIC 261818
  Complete submission text file 0001213900-20-015594.txt   8933682
Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55939 | Film No.: 20983111
SIC: 6770 Blank Checks